appDROGENO
how well-applied technology meets new challenges in the healthcare sector
the new professional bet for the fight against prostate cancer
Janssen is a research-based pharmaceutical company and part of the Johnson & Johnson Group.
For 125 years, Johnson & Johnson has been developing healthcare products and services for the pharmaceutical, professional, and consumer markets.
The challenge: Design, develop and support the release of Appdrogeno3.0 based on new technology, new UX/UI and following GxP guidelines (Good practice in the pharmaceutical industry).
oncology
strategy
The appDROGEN 3.0 application is aimed at healthcare professionals with prescribing capabilities in oncology clinical practice.
And is intended to help physicians diagnose prostate cancer, helping them to choose the best therapeutic strategy for each individual.
utilities
and tools
We created a series of tools and functionalities that help in the management of prostate cancer, such as PSA doubling time calculator (PSADT) or three-dimensional, multi-language and multi-country prostate.
As a result, the application offers various metrics at all different stages of the disease, aiming to simulate, pinpoint and zoom in on the different stages of the prostate tumor.
3D
simulation
On a technical level, it was a great adventure to immerse ourselves in 3D modeling applications.
Simulation of the genitourinary apparatus that allows to visualize and simulate the different stages of the prostate tumor.
Pointing out and enlarging the most interesting area, being able to send all the images with their annotations by mail, thus facilitating the explanation of the professional to the patient.
Medical websites following the guidelines of the GxP process (good practices in the pharmaceutical industry).
As well as drawing on the 3D image the most interesting areas for further studies.
